Abstract
Identification of high-risk atherosclerotic lesions prone to rupture and thrombosis may greatly decrease the morbidity and mortality associated with atherosclerosis. High-resolution magnetic resonance imaging (MRI) has recently emerged as one of the most promising techniques for the noninvasive study of atherothrombotic disease, as it can characterize plaque composition and monitor its progression. The development of MRI contrast agents that specifically target components of the atherosclerotic plaque may enable non-invasive detection of high-risk lesions. This review discusses the use of high-resolution MRI for plaque detection and characterization and the potentials of Molecular Imaging using a variety of molecules present in atherosclerotic plaques that may serve as targets for specific contrast agents to allow the identification of high-risk atherosclerotic lesions invivo. Ultimately, such agents may enable treatment of high-risk patients prior to lesion progression and occurrence of complications.
Keywords: Atherosclerosis, magnetic resonance imaging, coronary artery disease
Current Molecular Medicine
Title: Plaque Imaging and Characterization Using Magnetic Resonance Imaging: Towards Molecular Assessment
Volume: 6 Issue: 5
Author(s): Marc Sirol, Valentin Fuster and Zahi A. Fayad
Affiliation:
Keywords: Atherosclerosis, magnetic resonance imaging, coronary artery disease
Abstract: Identification of high-risk atherosclerotic lesions prone to rupture and thrombosis may greatly decrease the morbidity and mortality associated with atherosclerosis. High-resolution magnetic resonance imaging (MRI) has recently emerged as one of the most promising techniques for the noninvasive study of atherothrombotic disease, as it can characterize plaque composition and monitor its progression. The development of MRI contrast agents that specifically target components of the atherosclerotic plaque may enable non-invasive detection of high-risk lesions. This review discusses the use of high-resolution MRI for plaque detection and characterization and the potentials of Molecular Imaging using a variety of molecules present in atherosclerotic plaques that may serve as targets for specific contrast agents to allow the identification of high-risk atherosclerotic lesions invivo. Ultimately, such agents may enable treatment of high-risk patients prior to lesion progression and occurrence of complications.
Export Options
About this article
Cite this article as:
Sirol Marc, Fuster Valentin and Fayad A. Zahi, Plaque Imaging and Characterization Using Magnetic Resonance Imaging: Towards Molecular Assessment, Current Molecular Medicine 2006; 6 (5) . https://dx.doi.org/10.2174/156652406778018617
DOI https://dx.doi.org/10.2174/156652406778018617 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Low Osteopontin N-Terminal Fragment and Carotid Plaque Stability Associated with Statin or Antiplatelet Therapy
Current Vascular Pharmacology 23Na Magnetic Resonance Imaging for the Determination of Myocardial Viability: The Status and the Challenges
Current Vascular Pharmacology Preventing Atherosclerosis with Angiotensin-Converting Enzyme Inhibitors: Emphasis on Diabetic Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Conotoxins and Structural Biology: A Prospective Paradigm for Drug Discovery
Current Protein & Peptide Science Drug Discoveries Towards Kv1.5 Potassium Channel
Current Topics in Medicinal Chemistry Recent Patented Applications of Ion-Exchange Membranes in the Agrifood Sector
Recent Patents on Chemical Engineering Candidate Susceptibility Genes in Alzheimers Disease Are at High Risk for Being Forgotten - They Dont Give Peace of Mind...
Current Drug Metabolism Beclin 1 Biology and its Role in Heart Disease
Current Cardiology Reviews Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
Current Neuropharmacology Targeting the JNK Pathway for Therapeutic Benefit in CNS Disease
Current Drug Targets - CNS & Neurological Disorders Common Drugs for Stabilization of Renal Function in the Progression of Diabetic Nephropathy and Their Relations with Hypertension Therapy
Current Diabetes Reviews Advances and Progress in Chagas Disease Drug Discovery
Current Topics in Medicinal Chemistry Neurological Substrate of Central Auditory Processing Deficits in Children
Current Pediatric Reviews Antithrombin Abnormalities and Perinatal Management
Current Drug Targets A Possible Application of Memristors for Secondary Lightning Protection
Recent Advances in Electrical & Electronic Engineering GuidAge Study: A 5-Year Double Blind, Randomised Trial of EGb 761 for the Prevention of Alzheimers Disease in Elderly Subjects with Memory Complaints. I. Rationale, Design and Baseline Data
Current Alzheimer Research Influence of Lifestyle Measures on Hypertriglyceridaemia
Current Drug Targets Neonatal Formulations: The Need for a Tailored, Knowledge Driven Approach
Current Pharmaceutical Design A Novel Therapeutic Strategy Against Vascular Disorders with Chymase Inhibitor
Current Vascular Pharmacology Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease
Current Cardiology Reviews